Medical specialists from Norway tagged as investigators in clinical trials studying Carcinoma, Non-Small-Cell Lung

Total 11 results

Aslaug Helland, MD
Seen in:
- Oslo, Oslo University Hospital - Radiumhospitalet
Trials:
- NCT04127110 (Principal Investigator)
Conditions:
- Non Small Cell Lung Cancer
Bjørn Grønberg
Seen in:
- Sør-Trøndelag, Trondheim, St. Olavs hospital
Trials:
- NCT06119581 (Principal Investigator)
Conditions:
- Carcinoma, Non-Small-Cell Lung;
- Neoplasm Metastasis
Bjorn Henning Gronberg
Seen in:
- Trondheim, St. Olavs hospital
Trials:
- NCT06012435 (Principal Investigator)
Conditions:
- Carcinoma, Non-Small-Cell Lung
Christina Aamelfot
Seen in:
- Hordaland, Bergen, Haukeland Universitetssjukehus
Trials:
- NCT06119581 (Principal Investigator)
Conditions:
- Carcinoma, Non-Small-Cell Lung;
- Neoplasm Metastasis
Daniel Heinrich
Seen in:
- Oppland, Gjøvik, Sykehuset Innlandet HF Gjøvik
Trials:
- NCT06119581 (Principal Investigator)
Conditions:
- Carcinoma, Non-Small-Cell Lung;
- Neoplasm Metastasis
Kirill Neumann
Seen in:
- Akershus, Lørenskog, Akershus Universitetssykehus
Trials:
- NCT06119581 (Principal Investigator)
Conditions:
- Carcinoma, Non-Small-Cell Lung;
- Neoplasm Metastasis
Maria Moksnes Bjaanæs
Seen in:
- Oslo, GSK Investigational Site
Trials:
- NCT04475939 (Principal Investigator)
Conditions:
- Lung Cancer, Non-Small Cell
Odd Terje Brustugun
Seen in:
- Buskerud, Drammen, Drammen Sykehus, Vestre Viken HF
- Drammen, GSK Investigational Site
Trials:
- NCT04475939 (Principal Investigator)
- NCT05855200 (Principal Investigator)
- NCT06119581 (Principal Investigator)
Conditions:
Per Jönsson
Seen in:
- Lørenskog, GSK Investigational Site
Trials:
- NCT04475939 (Principal Investigator)
Conditions:
- Lung Cancer, Non-Small Cell
Tesfaye Madebo
Seen in:
- Rogaland, Stavanger, Stavanger Universitetssykehus
Trials:
- NCT06119581 (Principal Investigator)
Conditions:
- Carcinoma, Non-Small-Cell Lung;
- Neoplasm Metastasis
Vilde Drageset Haakensen
Seen in:
- Oslo, Oslo Universitetssykehus Ullevål
Trials:
- NCT04819100 (Principal Investigator)
- NCT06119581 (Principal Investigator)
Conditions:
- Carcinoma, Non-Small-Cell Lung;
- Neoplasm Metastasis

Clinical Trials on Carcinoma, Non-Small-Cell Lung

Sidney Kimmel Cancer Center at Thomas Jefferson...
Bristol-Myers Squibb

Completed

Nivolumab, Cisplatin, and Pemetrexed Disodium or Gemcitabine Hydrochloride in Treating Patients With Stage I-IIIA Non-small Cell Lung Cancer That Can Be Removed by Surgery

Stage IIIA Non-Small Cell Lung Cancer | Stage IIA Non-Small Cell Lung Carcinoma | Stage IIB Non-Small Cell Lung Carcinoma | Stage I Non-Small Cell Lung Cancer | Stage II Non-Small Cell Lung Cancer | Stage IA Non-Small Cell Lung Carcinoma | Stage IB Non-Small Cell Lung Carcinoma | Non-Squamous Non-Small...

United States
National Cancer Institute (NCI)

Completed

A Comparison of FLT to FDG PET/CT in the Early Assessment of Chemotherapy Response in Stage IB-IIIA Resectable NSCLC

Stage IIIA Non-Small Cell Lung Cancer | Recurrent Non-Small Cell Lung Carcinoma | Stage IV Non-Small Cell Lung Cancer | Stage IIA Non-Small Cell Lung Carcinoma | Stage IIB Non-Small Cell Lung Carcinoma | Stage IB Non-Small Cell Lung Carcinoma

United States
National Cancer Institute (NCI)

Terminated

Pioglitazone Hydrochloride in Treating Patients With Stage IA-IIIA Non-small Cell Lung Cancer

Stage IIIA Non-Small Cell Lung Cancer | Stage IIA Non-Small Cell Lung Carcinoma | Stage IIB Non-Small Cell Lung Carcinoma | Stage IA Non-Small Cell Lung Carcinoma | Stage IB Non-Small Cell Lung Carcinoma

United States
National Cancer Institute (NCI)

Terminated

Azacitidine and Entinostat in Treating Patients With Newly Diagnosed Stage IA-IIIA Non-Small Lung Cancer Undergoing Surgery

Stage IIIA Non-Small Cell Lung Cancer | Stage IIA Non-Small Cell Lung Carcinoma | Stage IIB Non-Small Cell Lung Carcinoma | Stage IA Non-Small Cell Lung Carcinoma | Stage IB Non-Small Cell Lung Carcinoma

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Active, not recruiting

Docetaxel, Cisplatin, and Erlotinib Hydrochloride in Treating Patients With Stage I-III Non-small Cell Lung Cancer Following Surgery

Stage IB Lung Non-Small Cell Carcinoma AJCC v7 | Stage IIA Lung Non-Small Cell Carcinoma AJCC v7 | Stage IIB Lung Non-Small Cell Carcinoma AJCC v7 | Stage IIIA Lung Non-Small Cell Cancer AJCC v7 | Recurrent Lung Non-Small Cell Carcinoma | Stage IIIB Lung Non-Small Cell Cancer AJCC v7 | Stage IA...

United States
University of Southern California
National Cancer Institute (NCI); Society of Thoracic Radiology

Active, not recruiting

Dynamic Perfusion Computed Tomography in Patients With Localized Non-small Cell Lung Cancer

Stage IIA Non-Small Cell Lung Carcinoma | Stage IIB Non-Small Cell Lung Carcinoma | Stage IA Non-Small Cell Lung Carcinoma | Stage IB Non-Small Cell Lung Carcinoma

United States
National Cancer Institute (NCI)

Active, not recruiting

Erlotinib Hydrochloride in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Completely Removed by Surgery (An ALCHEMIST Treatment Trial)

Lung Non-Squamous Non-Small Cell Carcinoma | Stage IB Lung Non-Small Cell Carcinoma AJCC v7 | Stage II Lung Non-Small Cell Cancer AJCC v7 | Stage IIA Lung Non-Small Cell Carcinoma AJCC v7 | Stage IIB Lung Non-Small Cell Carcinoma AJCC v7 | Stage IIIA Lung Non-Small Cell Cancer AJCC v7

United States, Puerto Rico
M.D. Anderson Cancer Center

Active, not recruiting

Nivolumab With or Without Ipilimumab or Chemotherapy in Treating Patients With Previously Untreated Stage I-IIIA Non-small Cell Lung Cancer

Stage IB Lung Non-Small Cell Carcinoma AJCC v7 | Stage II Lung Non-Small Cell Cancer AJCC v7 | Stage IIA Lung Non-Small Cell Carcinoma AJCC v7 | Stage IIB Lung Non-Small Cell Carcinoma AJCC v7 | Stage IIIA Lung Non-Small Cell Cancer AJCC v7 | Stage I Lung Non-Small Cell Cancer AJCC v7 | Stage...

United States
National Cancer Institute (NCI)

Active, not recruiting

Osimertinib and Navitoclax in Treating Patients With EGFR-Positive Previously Treated Advanced or Metastatic Non-small Cell Lung Cancer

Stage IIIA Lung Non-Small Cell Cancer AJCC v7 | Advanced Lung Non-Squamous Non-Small Cell Carcinoma | Metastatic Lung Non-Squamous Non-Small Cell Carcinoma | Stage IIIB Lung Non-Small Cell Cancer AJCC v7 | Stage IV Lung Non-Small Cell Cancer AJCC v7 | Stage III Lung Non-Small Cell Cancer AJCC...

United States
Alexander Chi

Not yet recruiting

Combining ICI With SBRT or HypoFrx-RT for ES NSCLC

Non-small Cell Lung Cancer Stage III | Non-small Cell Lung Cancer | Non-small Cell Lung Cancer Stage I | Non-small Cell Carcinoma | Non-small Cell Lung Cancer Stage II

China

Medical specialists from Norway tagged as investigators in clinical trials studying Carcinoma, Non-Small-Cell Lung

Clinical Trials on Carcinoma, Non-Small-Cell Lung

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Brazil

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations